Fairmount Partners Advises Pinnacle 21, a Leader in Data Standardization Software for Pharmaceutical Clinical Data, in its Sale to Certara

Complementary technologies accelerate and help assure success in the drug development process PRINCETON, NJ – October 4, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the completion of the previously announced transaction to acquire Pinnacle 21, a leading provider of SaaS solutions for clinical data fitness, regulatory compliance and submission readiness.  […]

Fairmount Partners Advises Cella in its Sale to Randstad

ATLANTA, GA – September 30, 2021 – Randstad NV, the global leader in the HR services industry, announces that its US business, Randstad USA has acquired Cella, a staffing, managed solutions and consulting firm for the creative, marketing, and digital market. The acquisition enables Randstad to build a strong position in the significant and growing US marketing, creative and digital staffing and […]

Fairmount Partners Advises Particle Dynamics in its Sale to BroadOak Capital Partners, Research Corporation Technologies, and Farragut Capital Partners

ST. LOUIS, MO – September 29, 2021 – Particle Dynamics, a global leader in particle processing, delivery technologies, and finished dose manufacturing for pharmaceutical, over-the-counter (“OTC”), and nutraceutical companies, has sold from Edgewater Capital Partners to a new ownership group led by BroadOak Capital Partners (“BroadOak”). The new ownership group comprises BroadOak, Research Corporation Technologies […]

Fairmount Partners Advises Pinnacle 21, a Leader in Data Standardization Software for Pharmaceutical Clinical Data, in its Pending Acquisition by Certara

Transaction accretive to Certara’s revenue, adjusted EBITDA, and adjusted EPS, subject to closing PRINCETON, NJ – August 5, 2021 – Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has signed a definitive agreement to acquire Pinnacle 21 for $310 million in cash and stock.  Pinnacle 21’s software tools are used to […]

Fairmount Partners Advises WCG in its Acquisition of Intrinsic Imaging

Acquisition Enriches WCG’s Scientific and Regulatory Capabilities with Comprehensive Services Ensuring Quality and Validity of Clinical Trial Results Across Drug, Medical Device and Artificial Intelligence Studies PRINCETON, NJ – July 13, 2021 – WCG has announced the acquisition of Intrinsic Imaging, a leading global provider of medical imaging core lab services. With over a decade […]

Fairmount Partners Advises OmniPoint Staffing, a Full-Service IT Staff Augmentation Firm, in its Sale to The Planet Group

Acquisition Allows for Further Expansion of Planet’s Technology Portfolio with Enhanced Staffing and Consulting Services CHICAGO, IL – June 28, 2021 – The Planet Group, a portfolio company of Odyssey Investment Partners and leading provider of outsourced human capital and consulting solutions, announced today that it has entered into an agreement to acquire OmniPoint Staffing, […]

Fairmount Partners Advises SDLC in its Sale to CitiusTech

PRINCETON, NJ – June 24, 2021 – CitiusTech, a leading provider of healthcare technology services, solutions and platforms, announced today that it has made a strategic acquisition of SDLC Partners (SDLC), a Pittsburgh, PA based provider of technology solutions to leading payer organizations. SDLC focuses on three key areas of payer technology needs – technology […]

Fairmount Partners Helps Antidote Raise $23 Million to Scale Digital Patient Engagement Services

The funding, led by LBO France, will be used to enhance Antidote’s platform and accelerate new data products, connecting patients to research globally. NEW YORK, NY – June 3, 2021 – Antidote Technologies Limited (“Antidote”) today announced it has closed $23.2 million in funding to expand its digital patient engagement programs and clinical trial recruitment services. […]

Fairmount Partners Advises The Avoca Group in Sale to WCG

The Avoca Group strengthens WCG’s position as an industry leader for accelerating clinical trial quality management and compliance transformation. PRINCETON, NJ – May 11, 2021 – WCG™, a leading provider of clinical trial solutions, announced its acquisition of The Avoca Group, a life sciences consulting firm supporting biopharma, biotech, CROs and clinical service providers, which is dedicated to improving […]

Fairmount Partners Advises Clinipace in Merger with dMed

The combined Company will provide full-service CRO services to meet needs of global fast-moving biotech, pharma and medical device companies, and to accelerate the delivery of innovative solutions to patients worldwide. SHANGHAI and MORRISVILLE, N.C – April 28, 2021 – dMed Global, a full-service Clinical Contract Research Organization (CRO) based in Shanghai, China, and Clinipace Incorporated, a full-service Clinical CRO […]